| Kerri Logan Deel, | |
|
668 W Main St, Abingdon, VA 24210-2510 | |
| (276) 628-2300 | |
| (276) 628-2708 |
| Full Name | Kerri Logan Deel |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 668 W Main St, Abingdon, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336452564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0000033853 (Tennessee) | Primary |
| 183500000X | Pharmacist | 014145 (Kentucky) | Secondary |
| 183500000X | Pharmacist | 0202208870 (Virginia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Kerri Logan Deel, 25604 Jomean Drive, Abingdon, VA 24211 Ph: () - | Kerri Logan Deel, 668 W Main St, Abingdon, VA 24210-2510 Ph: (276) 628-2300 |
News Archive
Contradicting the opinion of most policy experts, a draft report from the Trump administration forecasts better enrollment and lower premiums for everyone who buys their own health insurance if a controversial amendment proposed by Sen. Ted Cruz of Texas were to become law.
Federal legislation on health care reform and coverage expansion will have major impacts on cancer care. Community oncology professionals need to know how this legislation impacts them and their community practice. US Oncology, Inc., supporting the nation's foremost cancer treatment and research network, announced today that it will host a complimentary educational webinar for community-based oncology practices to discover how this new legislation will impact cancer care in 2010.
Each year, radon kills more people than home fires, drowning, falls or drunk driving. It is the number one cause of lung cancer in nonsmokers, taking some 21,000 lives annually.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
› Verified 3 days ago
Angela Marie Cooper, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-3050 | |
Dr. James Justin Wimmer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 668 W Main St, Abingdon, VA 24210 Phone: 276-628-2300 | |
Michael Justice, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Food City Circle, Abingdon, VA 24210 Phone: 276-623-5100 | |
James Russell Belcher, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 396 Town Centre Dr, Abingdon, VA 24210 Phone: 276-628-2580 | |
Justin Greer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 16000 Johnston Memorial Dr, Abingdon, VA 24211 Phone: 276-258-3050 | |
Kevin Scott Wood, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 795 Cummings Street, Abingdon, VA 24211 Phone: 276-258-5251 Fax: 276-258-5289 | |
Dr. Derek Webb, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 396 Towne Center Dr, Abingdon, VA 24210 Phone: 276-628-2580 Fax: 276-628-8043 |